STOCK TITAN

Ginkgo Bioworks to Participate in Two Conferences in May

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Ginkgo Bioworks (NYSE: DNA) announced its participation in two investor conferences in May. On May 22, 2024, Ryan Morhard, Senior Director of Policy and Partnerships, will join the virtual Sustainable API Manufacturing panel during TD Cowen's 2nd Annual Sustainability Week at 4:25 pm ET. On May 30, 2024, Ena Cratsenburg, Chief Business Officer, will host a fireside chat at 10:40 am CT (11:40 am ET) at the Leerink Partners Healthcare Crossroads Conference. Further details, webcast links, and replays will be available on the company's investor relations website.

Positive
  • Ginkgo Bioworks is actively engaging with the investor community by participating in prominent conferences.
  • The company's involvement in sustainability discussions highlights its commitment to environmental responsibility.
  • Participation in the conferences may increase visibility and investor interest in Ginkgo Bioworks.
Negative
  • The press release lacks specific financial data or business updates, which investors might find uninformative.
  • No new product announcements or significant business developments were disclosed.

BOSTON, May 15, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that management will be participating in two investor conferences in May.

  • TD Cowen's 2nd Annual Sustainability Week: Ginkgo's Senior Director of Policy and Partnerships, Ryan Morhard, will participate in the virtual Sustainable API Manufacturing panel at 4:25 pm ET on May 22, 2024.
  • Leerink Partners Healthcare Crossroads Conference: Ginkgo's Chief Business Officer, Ena Cratsenburg, will host a fireside chat at 10:40 am CT (11:40 am ET) on May 30, 2024.

Further details, webcast links, and a replay of the presentations, fireside chats, and panels, if available, will be posted on the company's investor relations website at investors.ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:
investors@ginkgobioworks.com

MEDIA CONTACT:
press@ginkgobioworks.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-to-participate-in-two-conferences-in-may-302145465.html

SOURCE Ginkgo Bioworks

FAQ

When is Ginkgo Bioworks participating in the TD Cowen's 2nd Annual Sustainability Week?

Ginkgo Bioworks will participate on May 22, 2024, at 4:25 pm ET.

Who from Ginkgo Bioworks will speak at the TD Cowen's 2nd Annual Sustainability Week?

Ryan Morhard, Senior Director of Policy and Partnerships, will participate in the panel.

When will Ginkgo Bioworks present at the Leerink Partners Healthcare Crossroads Conference?

Ginkgo Bioworks will host a fireside chat on May 30, 2024, at 10:40 am CT (11:40 am ET).

Who will represent Ginkgo Bioworks at the Leerink Partners Healthcare Crossroads Conference?

Ena Cratsenburg, Chief Business Officer, will host the fireside chat.

Where can I find the webcast links and replays of Ginkgo Bioworks' conference presentations?

Webcast links and replays will be posted on Ginkgo Bioworks' investor relations website.

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Stock Data

642.00M
1.73B
6.49%
82.87%
10.77%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
BOSTON